Concepedia

Marta Baro

MB

Statistics

Publications

13

Citations

580

H-Index

12

Active since

2008

Affiliations

Institut Català d'Oncologia(Current)

Yale University

Hospital de Sant Pau

Institut d'Investigació Biomédica de Bellvitge

Universidad de León

Marta Baro is an author at Institut Català d'Oncologia specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2008–2024

13

Publications

13

STING enhances cell death through regulation of reactive oxygen species and DNA damage

Thomas J. Hayman, Marta Baro, Tyler MacNeil et al. · Nature Communications · 2021 · 207 citations · Full text

, , +17

Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors

Cecilia López Sambrooks, Marta Baro, Amanda Quijano et al. · Cancer Research · 2018 · 70 citations · Full text

, , +14

Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB

Benjamin L. Lampson, Ana S. Ramίrez, Marta Baro et al. · Cell · 2024 · 47 citations · Full text

, , +17

Oligosaccharyltransferase Inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity

Marta Baro, Cecilia López Sambrooks, Amanda Quijano et al. · Clinical Cancer Research · 2018 · 43 citations · Full text

, , +17

Cetuximab May Inhibit Tumor Growth and Angiogenesis Induced by Ionizing Radiation: A Preclinical Rationale for Maintenance Treatment After Radiotherapy

Gemma Pueyo, Alicia Lozano, Marta Baro et al. · The Oncologist · 2010 · 36 citations

, , +15

1–5 of 13